INS and metabolic disease: In the absence of Sx16, adipocytes still exhibit robust insulin-stimulated glucose transport but exhibit altered behavior in response to hyperinsulinemic conditions and changed metabolic profiles, a result with potentially important implications for the development of metabolic disease.